IntelliGenome and Yu Shing Bio-Tech are partnering to commercialize a CRISPR-TB blood test in Taiwan.
1 report, 1 independent
Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
IntelliGenome and Yu Shing Bio-Tech are partnering to commercialize a CRISPR-TB blood test in Taiwan.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Taiwan Food and Drug Administration
Taiwan government agency
Nothing else this week.
Coverage
Newest first; wire copies grouped- newswise.comIntelliGenome Appoints Yu Shing Bio-Tech as Exclusive Distributor for CRISPR-TB in Taiwan | Newswise